Jenny E Ozga, James D Sargent, Alexander W Steinberg, Zhiqun Tang, Cassandra A Stanton, Laura M Paulin
{"title":"Childhood cigarette smoking is associated with health-related quality of life in older US adults.","authors":"Jenny E Ozga, James D Sargent, Alexander W Steinberg, Zhiqun Tang, Cassandra A Stanton, Laura M Paulin","doi":"10.18332/tid/204009","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Childhood smoking onset is associated with chronic obstructive pulmonary disease (COPD), independent of current smoking and smoking history. Its association with lower quality of life has not been tested. We examined the association between childhood smoking and measures of global health among older US adults.</p><p><strong>Methods: </strong>This study involved a cross-sectional survey of US adults ≥40 years (n=7056) from Wave 5 (2019) of the Population Assessment of Tobacco and Health Study. Ever smokers were asked when they began smoking regularly. Weighted multivariable analysis assessed onset of regular smoking at age of <15 years as a risk factor for lower Patient-Reported Outcomes Measurement Information System Global Physical and Mental Health (GPH and GMH) scores, adjusting for current smoking, smoking intensity, cigarette pack-years, secondhand smoke exposure, and other covariates. Sensitivity analysis added smoking-related disease comorbidities (e.g. COPD).</p><p><strong>Results: </strong>Sociodemographics were reflective of the US population aged ≥40 years, with 6.8% reporting childhood smoking and 16.9% current smoking. Mean (SD) for GPH and GMH were 14.8 (3.1) and 14.5 (3.8), respectively. In the multivariable analysis, compared to onset smoking at an older childhood age, GPH and GMH were significantly lower for those with early onset of smoking (-4.27%; 95% CI: -6.52 - -1.97 and -3.34%; 95% CI: -6.08 - -0.52; respectively). Global health was also negatively associated with current smoking, higher pack-years, and secondhand smoke exposure. The association between childhood smoking and GPH (but not GMH) remained significant after further adjustment for disease mediators.</p><p><strong>Conclusions: </strong>Childhood smoking was independently associated with lower quality of life among adults aged ≥40 years. Adverse effects of smoking on development during adolescence may have implications that extend beyond associations with chronic disease.</p>","PeriodicalId":23202,"journal":{"name":"Tobacco Induced Diseases","volume":"23 ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12285645/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tobacco Induced Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18332/tid/204009","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Childhood smoking onset is associated with chronic obstructive pulmonary disease (COPD), independent of current smoking and smoking history. Its association with lower quality of life has not been tested. We examined the association between childhood smoking and measures of global health among older US adults.
Methods: This study involved a cross-sectional survey of US adults ≥40 years (n=7056) from Wave 5 (2019) of the Population Assessment of Tobacco and Health Study. Ever smokers were asked when they began smoking regularly. Weighted multivariable analysis assessed onset of regular smoking at age of <15 years as a risk factor for lower Patient-Reported Outcomes Measurement Information System Global Physical and Mental Health (GPH and GMH) scores, adjusting for current smoking, smoking intensity, cigarette pack-years, secondhand smoke exposure, and other covariates. Sensitivity analysis added smoking-related disease comorbidities (e.g. COPD).
Results: Sociodemographics were reflective of the US population aged ≥40 years, with 6.8% reporting childhood smoking and 16.9% current smoking. Mean (SD) for GPH and GMH were 14.8 (3.1) and 14.5 (3.8), respectively. In the multivariable analysis, compared to onset smoking at an older childhood age, GPH and GMH were significantly lower for those with early onset of smoking (-4.27%; 95% CI: -6.52 - -1.97 and -3.34%; 95% CI: -6.08 - -0.52; respectively). Global health was also negatively associated with current smoking, higher pack-years, and secondhand smoke exposure. The association between childhood smoking and GPH (but not GMH) remained significant after further adjustment for disease mediators.
Conclusions: Childhood smoking was independently associated with lower quality of life among adults aged ≥40 years. Adverse effects of smoking on development during adolescence may have implications that extend beyond associations with chronic disease.
期刊介绍:
Tobacco Induced Diseases encompasses all aspects of research related to the prevention and control of tobacco use at a global level. Preventing diseases attributable to tobacco is only one aspect of the journal, whose overall scope is to provide a forum for the publication of research articles that can contribute to reducing the burden of tobacco induced diseases globally. To address this epidemic we believe that there must be an avenue for the publication of research/policy activities on tobacco control initiatives that may be very important at a regional and national level. This approach provides a very important "hands on" service to the tobacco control community at a global scale - as common problems have common solutions. Hence, we see ourselves as "connectors" within this global community.
The journal hence encourages the submission of articles from all medical, biological and psychosocial disciplines, ranging from medical and dental clinicians, through health professionals to basic biomedical and clinical scientists.